- Home
- ET vs GSK Comparison
ET vs GSK Comparison
Compare ET & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ET
- GSK
- Stock Information
- Founded
- ET 2002
- GSK 1715
- Country
- ET United States
- GSK United Kingdom
- Employees
- ET N/A
- GSK N/A
- Industry
- ET Natural Gas Distribution
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- ET Utilities
- GSK Health Care
- Exchange
- ET Nasdaq
- GSK Nasdaq
- Market Cap
- ET N/A
- GSK 74.6B
- IPO Year
- ET 2006
- GSK N/A
- Fundamental
- Price
- ET $18.95
- GSK $38.73
- Analyst Decision
- ET Strong Buy
- GSK Hold
- Analyst Count
- ET 12
- GSK 4
- Target Price
- ET $22.08
- GSK $47.00
- AVG Volume (30 Days)
- ET 15.5M
- GSK 4.7M
- Earning Date
- ET 05-07-2025
- GSK 04-30-2025
- Dividend Yield
- ET 6.87%
- GSK 4.00%
- EPS Growth
- ET 17.66
- GSK N/A
- EPS
- ET 1.28
- GSK 0.78
- Revenue
- ET $82,671,000,000.00
- GSK $39,280,393,592.00
- Revenue This Year
- ET $12.03
- GSK $7.60
- Revenue Next Year
- ET $3.13
- GSK $5.24
- P/E Ratio
- ET $14.56
- GSK $24.22
- Revenue Growth
- ET 5.20
- GSK 3.46
- 52 Week Low
- ET $14.90
- GSK $31.72
- 52 Week High
- ET $21.45
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- ET 52.03
- GSK 52.73
- Support Level
- ET $18.45
- GSK $37.76
- Resistance Level
- ET $19.13
- GSK $39.31
- Average True Range (ATR)
- ET 0.42
- GSK 0.52
- MACD
- ET 0.13
- GSK -0.26
- Stochastic Oscillator
- ET 94.78
- GSK 35.79
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.